Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
clinical trials
fda
life sciences
national blog main
san diego blog main
san diego top stories
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
aimmune therapeutics
akcea therapeutics
allergy
alnylam pharmaceuticals
anaphylaxis
andrew oxtoby
barry greene
bial
boston
boston university
boulder/denver blog main
boulder/denver top stories
dan ollendorf
daniel edelman
detroit blog main
detroit top stories
drug development
drugs
eosinophilic esophagitis
food allergy
hereditary transthyretin amyloidosis
immunotherapy
indiana blog main
indiana top stories
inotersen
jayson dallas
What
fda
3
×
time
3
×
friday
patients
add
agency
ago
aimmune
allergy
alnylam
approval
approve
approved
awaits
awarded
biological
called
carbidopa
combination
control
crossed
daily
decades
decision
developed
discovered
disease
drug
experience
fingers
gets
historic
immunotherapy
late
levodopa
medication
medicine
neurocrine
nod
oral
Language
unset
Current search:
fda
×
biotech
×
time
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision